The study demonstrated a poor prognosis overall for patients with acute myeloid leukemia (AML) who were previously treated ...

The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.

Mutations in one of the first human-isolated strains of H5N1 bird flu in the US were identified by the Texas Biomedical ...

Cemiplimab significantly reduced the risk of recurrence or death in patients with high-risk cutaneous squamous cell carcinoma ...

Women who are using heroin and were recently incarcerated had increased stimulant use, which is associated with adverse ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their ...

The Affordable Care Act (ACA) led to reductions in out-of-pocket costs and improvements in health among adults entering ...

The Bruton tyrosine kinase inhibitor was approved in combination with bendamustine and rituximab in previously untreated ...

With emergency evacuation orders requiring swift action, less mobile individuals, such as those with disabilities or the ...

Semaglutide (Ozempic) is 1 of 15 medications that will be included in yearly price negotiations between Medicare and ...

The combination treatment specifically targets KRAS-mutated metastatic colorectal cancer (CRC) to improve progression-free ...